Orion OYJ (OTCMKTS:ORINY) Sets New 52-Week High – Time to Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price reached a new 52-week high on Thursday . The stock traded as high as $46.00 and last traded at $46.00, with a volume of 108 shares traded. The stock had previously closed at $45.8150.

Orion OYJ Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The firm has a market cap of $12.98 billion, a price-to-earnings ratio of 18.93 and a beta of 0.07. The stock’s fifty day moving average price is $42.57 and its 200-day moving average price is $40.05.

Orion OYJ (OTCMKTS:ORINY) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The firm had revenue of $606.38 million for the quarter.

About Orion OYJ

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.